AML clinical trials
Access comprehensive clinical trial information for AML through Pure Global AI's free database. This collection includes 63 clinical trials across multiple phases including N/A, Phase 1, Early Phase 1. Currently, 19 trials are actively recruiting participants.
Research for AML is being conducted in China, United States of America, Spain and 7+ other countries. Leading sponsors include Zhejiang University and Institute of Hematology & Blood Diseases Hospital, China. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 63 clinical trials studying AML, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Zhejiang University, Institute of Hematology & Blood Diseases Hospital, China, PETHEMA Foundation, among others.